Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 418,305 | 438,737 | 563,340 | 659,200 | 114,424 |
| Cost of Goods | 114,423 | 39,211 | 30,127 | 38,406 | 9,306 |
| Gross Profit | 303,882 | 399,526 | 533,213 | 620,794 | 105,118 |
| Operating Expenses | 315,075 | 308,088 | 309,438 | 405,493 | 271,314 |
| Operating Income | -10,770 | 91,649 | 223,902 | 215,707 | -165,890 |
| Interest Expense | 0 | 0 | 11,659 | 7,059 | 6,962 |
| Other Income | -3,635 | -3,741 | -1,442 | -8,038 | -2,018 |
| Pre-tax Income | -14,405 | 87,908 | 210,801 | 200,610 | -174,870 |
| Income Tax | 20,063 | 32 | 22,660 | -27,842 | 24,448 |
| Net Income Continuous | -34,468 | 87,876 | 188,141 | 228,452 | -199,318 |
| Minority Interests | 30,463 | -3,714 | 29,512 | 7,342 | -25,249 |
| Net Income | $-64,931 | $91,590 | $158,629 | $221,110 | $-174,069 |
| EPS Basic Total Ops | -0.31 | 0.44 | 0.80 | 1.06 | -0.85 |
| EPS Basic Continuous Ops | -0.16 | 0.42 | 0.94 | 1.11 | -0.98 |
| EPS Diluted Total Ops | -0.31 | 0.43 | 0.84 | 1.02 | -0.85 |
| EPS Diluted Continuous Ops | -0.16 | 0.40 | 1.00 | 1.04 | -0.98 |
| EBITDA(a) | $-2,105 | $100,209 | $233,626 | $223,457 | $-157,181 |